Article

The probiotic effectiveness in experimental colitis is correlated with gut microbiome and host genetic features

2018-06-06

Abstract excerpt

Current evidence to support extensive use of probiotics in inflammatory bowel disease is limited and factors contribute to the inconsistent effectiveness of clinical probiotic therapy are not completely known. Here, as a proof-of-concept, we utilized Bifidobacterium longum JDM 301, a widely used commercial probiotic strain in China, to study potential factors that may influence the beneficial effect of probiotics...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dd6d7fd0-d265-5dae-b12d-3c5cf11dc26e
DOI: 10.1101/340331

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The probiotic effectiveness in experimental colitis is correlated with gut microbiome and host genetic featuresDOI 10.1101/340331Read

The Lactobacillus gasseri G098 Strain Mitigates Symptoms of DSS-Induced Inflammatory Bowel Disease in MiceSemantic proximity Read

Modulation of gut microbiota and anti-inflammatory effect of a probiotic cocktail in an inflammatory bowel disease-induced mouse model by fecal transplantationSemantic proximity Read

Impacts of diets fed after weaning on gut microbiota and susceptibility to DSS-induced colitis in miceSemantic proximity Read

Immunomodulatory Effects of a Probiotic Mixture: Alleviating Colitis in a Mouse Model through Modulation of Cell Activation Markers and the Gut MicrobiotaSemantic proximity Read

Lactobacillus plantarum ZJ316 alleviates ulcerative colitis by inhibiting inflammation and regulating short-chain fatty acid levels and the gut microbiota in a mouse modelSemantic proximity Read

Enhancing recovery from gut microbiome dysbiosis and alleviating DSS-induced colitis in mice with a consortium of rare short-chain fatty acid-producing bacteriaSemantic proximity Read

Enhancing Recovery from Gut Microbiome Dysbiosis and Alleviating DSS-Induced Colitis in Mice with a Consortium of Rare Short-Chain Fatty Acid-Producing BacteriaSemantic proximity Read

Dynamic Changes in Gut Microbiome of Ulcerative Colitis: Initial Study from Animal ModelSemantic proximity Read

Differential colitis susceptibility of Th1- and Th2-biased mice: A multi-omics approachSemantic proximity Read

Differential Susceptibility of the Gut Microbiota to DSS Treatment Interferes in the Conserved Microbiome Association in Mouse Models of Colitis and Is Related to the Initial Gut Microbiota DifferenceSemantic proximity Read

Core Gut Bacteria Analysis of Healthy MiceSemantic proximity Read

Pretreatment with yeast derived complex dietary-polysaccharide leads to suppressed gut inflammation, altered microbiota composition and increased immune regulatory short-chain fatty acid production in C57BL/6 miceSemantic proximity Read